PCP
QGEN icon

Perbak Capital Partners’s Qiagen QGEN Stock Holding History

Perbak Capital Partners’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-96,094
Closed -$4.32M – 372
2025
Q4 		$4.32M Sell
96,094
-8,744
-8% -$404K 1.32% 11
2025
Q3 		$4.68M Buy
104,838
+46,002
+78% +$2.2M 0.82% 13
2025
Q2 		$2.83M Buy
58,836
+43,979
+296% +$1.91M 0.64% 24
2025
Q1 		$597K Sell
14,857
-18,273
-55% -$769K 0.44% 33
2024
Q4 		$1.52M Buy
+33,130
New +$1.48M 0.81% 31

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perbak Capital Partners's QGEN Position: Q1 2026 in Review

Perbak Capital Partners sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 96,094 shares — an estimated $4.32M sold.

Perbak Capital Partners first reported a position in QGEN in Q4 2024 and held it in 5 quarters. The position peaked at $4.68M in Q3 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Perbak Capital Partners reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 96,094 Qiagen shares in Q1 2026, an estimated $4.32M.
  • Perbak Capital Partners first reported a position in Qiagen in Q4 2024 and held it in 5 quarters.
  • Perbak Capital Partners's Qiagen position peaked at $4.68M in Q3 2025.
  • 346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.